JD

Jutta Deckert

DS Debiopharm International S.A.: 6 patents #1 of 44Top 3%
IM Immunogen: 5 patents #34 of 119Top 30%
SA Sanofi: 1 patents #1,013 of 1,881Top 55%
SA Sanofi-Aventis: 1 patents #285 of 563Top 55%
📍 Lexington, MA: #399 of 2,299 inventorsTop 20%
🗺 Massachusetts: #9,595 of 88,656 inventorsTop 15%
Overall (All Time): #361,184 of 4,157,543Top 9%
13
Patents All Time

Issued Patents All Time

Showing 1–13 of 13 patents

Patent #TitleCo-InventorsDate
12239732 Anti-CD37 immunoconjugate and anti-CD20 antibody combinations Angela ROMANELLI, Rodrigo R. RUIZ-SOTO, Jose F. Ponte, Jan PINKAS 2025-03-04
11466095 CD37-binding molecules and immunoconjugates thereof Peter U. Park, Daniel Tavares, Lingyun Rui 2022-10-11
11395796 Anti-CD37 immunoconjugate and anti-CD20 antibody combinations Angela ROMANELLI, Rodrigo R. RUIZ-SOTO, Jose F. Ponte, Jan PINKAS 2022-07-26
11104740 Antibodies and assays for detection of CD37 Daniel Tavares, Lingyun Rui, Sven Loebrich, Meghan Puopolo 2021-08-31
10556958 CD37-binding molecules and immunoconjugates thereof Julianto Setiady, Peter U. Park 2020-02-11
10202460 CD37-binding molecules and immunoconjugates thereof Peter U. Park, Daniel Tavares, Lingyun Rui 2019-02-12
9447189 CD37-binding molecules and immunoconjugates thereof Julianto Setiady, Peter U. Park 2016-09-20
9346887 CD37-binding molecules and immunoconjugates thereof Peter U. Park, Daniel Tavares, Lingyun Rui 2016-05-24
9314522 Antitumors combinations containing antibodies recognizing specifically CD38 and bortezomib Pascale LEJEUNE, Michele Mayo, Peter U. Park 2016-04-19
9175086 CD20 antibodies and uses thereof Daniel Tavares, Peter U. Park 2015-11-03
9173961 CD20 antibodies and uses thereof Lingyun Rui, Peter U. Park 2015-11-03
8765917 CD37-binding molecules and immunoconjugates thereof Peter U. Park, Daniel Tavares, Lingyun Rui 2014-07-01
8153765 Anti-CD38 antibodies for the treatment of cancer Peter U. Park, Laura M. Bartle, Anna Skaletskaya, Viktor Golmakher, Daniel Tavares +2 more 2012-04-10